导师风采

Public affairs

李文忠

干细胞生物材料研究组

 

李文忠

 

新加坡国立大学博士、德国干细胞治疗临床转换中心 博士后柏林再生医学中心德国亥姆霍兹国家研究中心联合会生物材料研究所研究员、柏林自由大学化学和生物化学研究所课题组长、温医大眼视光学院课题组长、博士生导师、浙江省特聘专家,发表SCI文章70余篇,曾指导德国医学博士2名,博士研究生10余名。

 

Email: BCRTLWZ@gmail.com

 

招生专业

 

化学材料医学,生物学,生物工程

 

研究方向

 

生物医学材料干细胞组织工程生物芯片纳米医学生物材料与干细胞调控

 

代表性论著

 

  1. Pan Y, Zhou S, Li Y, Parshad B, Li W*, Haag R. Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells. Journal of Controlled Release. 2020 in press IF: 7.90

  2. Zhou S, Pan Z, Zhang J, Li Y, Neumann F, Schwerdtle T, Li W*, Haag R. Dendritic polyglycerol-conjugated gold nanostars with different densities of functional groups to regulate osteogenesis from human mesenchymal stem cells. Nanoscale. 2020 in press IF: 6.97

  3. Chen J, Yu L, Li Y, CuellarCamacho JL, Chai Y, Li D, Li Y, Liu H, Ou L, Li W*, Haag R. Biospecific monolayer coating for multivalent capture of circulating tumor cells with high sensitivity. Advanced functional materials. 2019; 28: 1808961. IF: 16.83

  4. Zhang J, Cheng C, Cuellar-Camacho JL, Li M, Xia Y, Li W*, Haag R. Thermally responsive microfibers mediated stem cell fate via reversibly dynamic mechanical stimulation. Advanced functional materials. 2018; 28: 1804773. IF: 16.83

  5. Ren X, Feng Y, Guo J, Wang H, Li Q, Yang J, Hao X, Lv J, Ma N, Li W. Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. Chemical Society Reviews. 2015; 44: 5680-5742. IF: 42.84

  6. Gaebel R, Ma N, Liu J, Guan J, Koch L, Klopsch C, Gruene M, Toelk A, Wang W, Mark P, Wang F, Chichkov B, Li W*, Steinhoff G. Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials, 2011; 32: 9218-9230. IF: 10.27

  7. Gaebel R, Furlani D, Sorg H, Polchow B, Frank J, Bieback K, Wang W, Klopsch C, Ong L, Li W*, Ma N, Steinhoff G. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS ONE, 2011; 6: e15652. IF: 4.351

  8. Klopsch C, Furlani D, GäbelR, Li W*, Ugurlucan M, Kundt G, Zingler C, Titze U, Wang W, Ong L, Wagner K, Li R, Ma N, Steinhoff G. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. Journal of Cellular and Molecular Medicine, 2009; 13: 664-679. IF: 6.81

  9. Furlani D, Li W++, Pittermann E, Klopsch C, Wang L, Knopp A, Jungebluth P, Thedinga E, Havenstein C, Westien I, Ugurlucan M, Li RK, Ma N, Steinhoff G. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplantation, 2009; 18: 319-331. IF: 5.25

  10. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, Steinhoff G. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells, 2007; 25: 2118-2127. IF: 11.27